Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Post by investright12on Mar 12, 2020 8:46am

163 Views

Post# 30797862

Why AGN will hit $.45 today

italy hospital beds are FULL

NBA suspended season

Europe USA airline ban

Bill and Melinda Gates announces they are looking to fund COVID 19 drug ASAP...AGN has excellent candidate

Korea has been tryng compassionate supply of AGN drug...if results are positive..will be a monster MEDIA conference call

For the joker wh is trying to cover his $.10 short on this spread(french dude)...better put it to bed before you get totally wiped out to a $2

MY CALL TODAY IS AGN.WT TO $.35 and AGN to $.45